Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Travere Therapeutics Inc TVTX

Travere Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on identifying, developing, and delivering life-changing therapies to people living with rare kidney and metabolic diseases. Its product, FILSPARI (sparsentan), is indicated to reduce proteinuria in adults with primary IgAN at risk of rapid disease progression. Sparsentan is also in late-stage development for... see more

NDAQ:TVTX - Post Discussion

Travere Therapeutics Inc > Travere Therapeutics to Present at the H.C. Wainwright 3rd A
View:
Post by whytestocks on Jul 08, 2024 5:02pm

Travere Therapeutics to Present at the H.C. Wainwright 3rd A

Breaking News: $TVTX Travere Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference | BenzingaSAN DIEGO, July 08, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ:TVTX) today announced that company management will present at t...TVTX - Travere Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference | Benzinga
Be the first to comment on this post